BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 27492541)

  • 1. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
    Putcha N; Fawzy A; Paul GG; Lambert AA; Psoter KJ; Sidhaye VK; Woo J; Wells JM; Labaki WW; Doerschuk CM; Kanner RE; Han MK; Martinez C; Paulin LM; Martinez FJ; Wise RA; O'Neal WK; Barr RG; Hansel NN;
    Ann Am Thorac Soc; 2018 Jun; 15(6):710-717. PubMed ID: 30726108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.
    Rennard SI; Locantore N; Delafont B; Tal-Singer R; Silverman EK; Vestbo J; Miller BE; Bakke P; Celli B; Calverley PM; Coxson H; Crim C; Edwards LD; Lomas DA; MacNee W; Wouters EF; Yates JC; Coca I; Agustí A;
    Ann Am Thorac Soc; 2015 Mar; 12(3):303-12. PubMed ID: 25642832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.
    Crisafulli E; Costi S; Luppi F; Cirelli G; Cilione C; Coletti O; Fabbri LM; Clini EM
    Thorax; 2008 Jun; 63(6):487-92. PubMed ID: 18203818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbidities on COPD-specific health-related quality of life.
    Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
    Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis.
    Yoon HY; Park SY; Lee CH; Byun MK; Na JO; Lee JS; Lee WY; Yoo KH; Jung KS; Lee JH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1389-1397. PubMed ID: 31388298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with increasing COPD assessment test scores within 3 years.
    Irie H; Chubachi S; Sato M; Tsutsumi A; Nakachi I; Miyao N; Nishio K; Nakamura H; Asano K; Betsuyaku T
    Respir Med; 2017 Oct; 131():101-108. PubMed ID: 28947014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.
    Rubinsztajn R; Przybyłowski T; Grabicki M; Karwat K; Maskey-Warzęchowska M; Batura-Gabryel H; Chazan R
    Adv Clin Exp Med; 2019 Mar; 28(3):319-324. PubMed ID: 30943332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study.
    de Torres JP; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Cosio B; Casanova C;
    Respirology; 2018 May; 23(5):485-491. PubMed ID: 29027309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of comorbid factors that increase the COPD assessment test scores.
    Miyazaki M; Nakamura H; Chubachi S; Sasaki M; Haraguchi M; Yoshida S; Tsuduki K; Shirahata T; Takahashi S; Minematsu N; Koh H; Nakamura M; Sakamaki F; Terashima T; Sayama K; Jones PW; Asano K; Betsuyaku T;
    Respir Res; 2014 Feb; 15(1):13. PubMed ID: 24502760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life.
    van Boven JF; Román-Rodríguez M; Palmer JF; Toledo-Pons N; Cosío BG; Soriano JB
    Chest; 2016 Apr; 149(4):1011-20. PubMed ID: 26836892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups.
    Kim S; Lim MN; Hong Y; Han SS; Lee SJ; Kim WJ
    BMC Pulm Med; 2017 Dec; 17(1):209. PubMed ID: 29246211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and COPD severity in a clinic-based cohort.
    Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
    BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.